Imatinib Mesylate in Chronic Myeloid Leukemia

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 249-251

Bentham Science Publishers

Access to resources Recommend Favorite

Bilateral Hypopyon as the Presenting Feature of Chronic Myeloid Leukemia

By Sudharshan Sridharan   Kumari Anjana   Biswas Jyotirmay  

Ocular Immunology and Inflammation, Vol. 16, Iss. 5-6, 2008-09 ,pp. : 244-246

Informa Healthcare

Access to resources Recommend Favorite

Non-treatment-related chronic myeloid leukemia as a second malignancy

By Specchia G.   Buquicchio C.   Albano F.   Liso A.   Pannunzio A.   Mestice A.   Rizzi R.   Pastore D.   Liso V.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 115-119

Elsevier

Access to resources Recommend Favorite

Chronic idiopathic neutropenia preceding polymyalgia rheumatica and acute myeloid leukemia

By Megalakaki A.  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 791-792

Springer Publishing Company

Access to resources Recommend Favorite

Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia

By Galanopoulos A.  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 281-282

Springer Publishing Company

Access to resources Recommend Favorite